CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Down 92.8% in May

CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Down 92.8% in May

CBD Life Sciences Inc. (OTCMKTS:CBDLGet Rating) saw a significant decline in short interest in May. As of May 15th, there was short interest totalling 12,200 shares, a decline of 92.8% from the April 30th total of 169,300 shares. Based on an average daily trading volume, of 125,736,100 shares, the short-interest ratio is currently 0.0 days.

Shares of OTCMKTS:CBDL traded up $0.00 during mid-day trading on Wednesday, reaching $0.00. The stock had a trading volume of 28,238,040 shares, compared to its average volume of 82,140,492. CBD Life Sciences has a 1 year low of $0.00 and a 1 year high of $0.00.

About CBD Life Sciences (Get Rating)

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Featured Stories

Receive News & Ratings for CBD Life Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CBD Life Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.

Source link


Please enter your comment!
Please enter your name here